Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 110, Issue 11, Pages 2804-2811
Publisher
Springer Nature
Online
2014-04-16
DOI
10.1038/bjc.2014.198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiologic Approaches to Evaluating the Potential for Human Papillomavirus Type Replacement Postvaccination
- (2013) J. E. Tota et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
- (2013) Kimberley Kavanagh et al. BMC INFECTIOUS DISEASES
- Achieving high and equitable coverage of adolescent HPV vaccine in Scotland
- (2013) Katy Sinka et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
- (2013) A. Szarewski et al. JOURNAL OF INFECTIOUS DISEASES
- Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
- (2012) S. N. Tabrizi et al. JOURNAL OF INFECTIOUS DISEASES
- The value of HPV vaccination
- (2012) NATURE MEDICINE
- Human Papillomavirus Vaccine Introduction – The First Five Years
- (2012) Lauri E. Markowitz et al. VACCINE
- Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
- (2012) Cecilia M. Roteli-Martins et al. Human Vaccines & Immunotherapeutics
- Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx
- (2011) E Junor et al. BRITISH JOURNAL OF CANCER
- HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland
- (2011) M C O'Leary et al. BRITISH JOURNAL OF CANCER
- Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines
- (2011) Barbara Romanowski Human vaccines & immunotherapeutics
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
- (2011) Aimée R. Kreimer et al. JNCI-Journal of the National Cancer Institute
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Acceptability and response to a postal survey using self-taken samples for HPV vaccine impact monitoring
- (2011) K. Sinka et al. SEXUALLY TRANSMITTED INFECTIONS
- Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines
- (2010) K Cuschieri et al. BRITISH JOURNAL OF CANCER
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now